Mechanisms of zolpidem‐induced long<scp>QT</scp>syndrome: acute inhibition of recombinant<scp>hERG K</scp><sup>+</sup>channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells
J Jehle(Heidelberg University), Dierk Thomas(Heidelberg University)
Cited by 15
Related Papers
Upregulation of K <sub>2P</sub> 3.1 K <sup>+</sup> Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation
|Circulation|2015|195
Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model
|Cardiovascular Research|2011|159
Feasibility Study on Cardiac Arrhythmia Ablation Using High-Energy Heavy Ion Beams
|Scientific Reports|2016|121
Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study
|European Heart Journal|2011|103